Abstract
The biology of acute myeloid leukemia (AML) is complex and includes both genetic and epigenetic aberrations. We addressed the combined consequences of promoter hypermethylation of p15, CDH1, ER, MDR1, and RARB2 and mutation of NPM1, CEBPA, FLT3, and WT1 in a Danish cohort of 70 pediatric and 383 adult AML patients.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Pediatric Blood & Cancer |
| Vol/bind | 58 |
| Udgave nummer | 4 |
| Sider (fra-til) | 525-31 |
| Antal sider | 7 |
| ISSN | 1545-5009 |
| DOI | |
| Status | Udgivet - 2012 |